Zentalis Pharmaceuticals growth metrics data for the quarter ended Jun 2026. These growth metrics cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||||||||||||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -1497.00 | -568.00 | 420.00 | 2,213.00 | 321.00 | -440.00 | -378.00 | -1000.00 | -338.00 | -725.00 | 659.00 | 971.00 | 560.00 | 1,093.00 | -1804.00 | -713.00 | -592.00 | -683.00 | 926.00 | -1533.00 | |||||
| Return on Assets [ROA] Growth (3y)ROA Growth (3y) | 1,801.00 | -586.00 | -1514.00 | -1734.00 | 701.00 | 2,185.00 | 543.00 | -72.00 | -1523.00 | -742.00 | -371.00 | -315.00 | -219.00 | -1275.00 | |||||||||||
| Return on Assets [ROA] Growth (5y)ROA Growth (5y) | 656.00 | -328.00 | -1547.00 | -1324.00 | -177.00 | -62.00 | |||||||||||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 1,548.00 | 656.00 | -290.00 | 300.00 | -344.00 | -106.00 | -228.00 | -322.00 | 317.00 | -492.00 | 1,156.00 | -10.00 | -94.00 | 41.00 | -1740.00 | 1,081.00 | 27.00 | -50.00 | -132.00 | -1378.00 | |||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -3415.00 | -2016.00 | -934.00 | 1,317.00 | 1,992.00 | 643.00 | 679.00 | -152.00 | -678.00 | -1239.00 | -71.00 | 640.00 | 175.00 | 1,068.00 | -739.00 | -747.00 | -440.00 | -697.00 | -224.00 | -2239.00 | |||||
| Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) | 2,604.00 | -913.00 | -2101.00 | -2612.00 | -327.00 | 1,805.00 | 1,489.00 | 472.00 | -131.00 | -259.00 | -942.00 | -868.00 | -1034.00 | -2346.00 | |||||||||||
| Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) | 1,794.00 | -1021.00 | -2365.00 | -2241.00 | -1290.00 | -1181.00 | |||||||||||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 105.00 | 1,114.00 | -394.00 | 491.00 | 780.00 | -234.00 | -359.00 | -339.00 | 255.00 | -796.00 | 810.00 | 372.00 | -210.00 | 96.00 | -997.00 | 364.00 | 97.00 | -161.00 | -524.00 | -1651.00 | |||||
| Return on Sales [ROS] Growth (1y)ROS Growth (1y) | -72827.00 | -13727.00 | -9922.00 | ||||||||||||||||||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -48271.00 | 2,783.00 | 33,039.00 | -60377.00 | 10,828.00 | 6,588.00 |